Subscribe to our monthly newsletter.

Share this item

The investments in the future have paid off for L.B. Bohle Maschinen + Verfahren GmbH in the 2015 business year: The special machine builder for the pharmaceutical industry increased its turnover by 26 per- cent to EUR 48 million. CEO Lorenz Bohle lists the success stories: “We have won a prestigious contract from a global leader in the US, despite strong competition. In Russia alone, we generated EUR 6 million. And we have several major projects running in South America and Mexico.” For 2016, he forecasts “a growth rate between ten and 15 percent”.

With the opening of the Technology Center and the symposium on continuous processing, L.B. Bohle has created a first-class platform for the development of innovative processes in March 2015. Customers, scientists and cooperation partners increasingly draw on the unique system for experimental and testing purposes. According to Lorenz Bohle, “permanent and process-overlapping measurement, monitoring and production control are the key to pushing continuous production.”

In cooperation with the experts of the universities RWTH Aachen and HHU Düsseldorf, the foundation for a modular and quality-oriented production platform in line with state-of-the-art pharmaceutical technology are being defined and put into practice at L.B. Bohle.



Read the full article here: https://www.lbbohle.com/company/press-section/press-release/479-l-b-bohle-increases-turnover-to-eur-48-million